OncoAlert and ecancer weekly roundup for August 17-23 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for August 17-23 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
24 Aug 2020

OncoAlert and ecancer weekly roundup for August 1-8 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for August 1-8 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Aug 2020

OncoAlert and ecancer weekly roundup for July 19-25 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for July 19-25 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
27 Jul 2020

Why the ADAURA study is a big step forward for NSCLC

Dr Luis Raez - Memorial Cancer Institute, Florida, USA
Why the ADAURA study is a big step forward for NSCLC ( Dr Luis Raez - Memorial Cancer Institute, Florida, USA )
17 Jul 2020

Lung cancer updates from ASCO 2020

Dr Luis Raez - Memorial Cancer Institute, Florida, USA
Lung cancer updates from ASCO 2020 ( Dr Luis Raez - Memorial Cancer Institute, Florida, USA )
17 Jul 2020

Background of the KEYNOTE-158 trial for pembrolizumab in advanced mesothelioma

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Background of the KEYNOTE-158 trial for pembrolizumab in advanced mesothelioma ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
15 Jul 2020

Novel immunotherapy approaches for small cell lung cancer

Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York City, USA
Novel immunotherapy approaches for small cell lung cancer ( Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York City, USA )
15 Jul 2020

Checkmate 9LA: Nivolumab, ipilimumab and chemotherapy for stage IV NSCLC

Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Checkmate 9LA: Nivolumab, ipilimumab and chemotherapy for stage IV NSCLC ( Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
30 Jun 2020

Preclinical models for small-cell lung cancer

Prof Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands
Preclinical models for small-cell lung cancer ( Prof Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands )
18 Jun 2020

CITYSCAPE: Tiragolumab plus atezolizumab for non-small cell lung cancer

Dr Melissa Johnson - Sarah Cannon Research Institute, Nashville, USA
CITYSCAPE: Tiragolumab plus atezolizumab for non-small cell lung cancer ( Dr Melissa Johnson - Sarah Cannon Research Institute, Nashville, USA )
17 Jun 2020

High-dose twice daily thoracic radiotherapy in limited disease small-cell lung cancer

Prof Bjørn Henning Grønberg - Trondheim University Hospital, Trondheim, Norway
High-dose twice daily thoracic radiotherapy in limited disease small-cell lung cancer ( Prof Bjørn Henning Grønberg - Trondheim University Hospital, Trondheim, Norway )
15 Jun 2020

Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung cancer

Dr Julia Rotow - Dana Farber Cancer Institute, Boston, USA
Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung cancer ( Dr Julia Rotow - Dana Farber Cancer Institute, Boston, USA )
12 Jun 2020